# EDGAR Filing Document

**Accession Number:** 0001833141
**File Stem:** 0001062993-26-001302
**Filing Date:** 2026-3
**Character Count:** 5194
**Document Hash:** de6ce98924397723364e46a6fba8892b
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**0001062993-26-001302.hdr.sgml**: 20260305

**ACCESSION NUMBER**: 0001062993-26-001302

**CONFORMED SUBMISSION TYPE**: 6-K

**PUBLIC DOCUMENT COUNT**: 1

**CONFORMED PERIOD OF REPORT**: 20251231

**FILED AS OF DATE**: 20260305

**DATE AS OF CHANGE**: 20260305

**FILER**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** CYBIN INC.
- **CENTRAL INDEX KEY:** 0001833141
- **STANDARD INDUSTRIAL CLASSIFICATION:** PHARMACEUTICAL PREPARATIONS [2834]
- **ORGANIZATION NAME:** 03 Life Sciences
- **EIN:** 000000000
- **STATE OF INCORPORATION:** A6
- **FISCAL YEAR END:** 0331

**FILING VALUES:**
- **FORM TYPE:** 6-K
- **SEC ACT:** 1934 Act
- **SEC FILE NUMBER:** 001-40673
- **FILM NUMBER:** 26724075

**BUSINESS ADDRESS:**
- **STREET 1:** 100 KING STREET WEST
- **STREET 2:** SUITE 5600
- **CITY:** TORONTO
- **STATE:** A6
- **ZIP:** M5X 1C9
- **BUSINESS PHONE:** (908) 764-8385

**MAIL ADDRESS:**
- **STREET 1:** 100 KING STREET WEST
- **STREET 2:** SUITE 5600
- **CITY:** TORONTO
- **STATE:** A6
- **ZIP:** M5X 1C9

------

**UNITED STATES**<br>**SECURITIES AND EXCHANGE COMMISSION**<br>Washington, D.C. 20549<br>**Form 6-K**<br>**REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16**<br>**UNDER THE SECURITIES EXCHANGE ACT OF 1934**

For the month of <u>**March, 2026.**</u>

Commission File Number: <u>**001-40673**</u>

<br><u>**Cybin Inc.**</u><br>(Exact Name of Registrant as Specified in Charter)<br>**<u>100 King Street West, Suite 5600, Toronto, Ontario, M5X 1C9</u>** 

(Address of principal executive offices)

Indicate by check mark whether the registrant files or will file annual reports under cover Form 20-F or Form 40-F.

Form 20-F □ Form 40-F ⊠

**<br>EXPLANATORY NOTE**

Cybin Inc. (the "Company") is furnishing this Form 6-K (the "Form 6-K") solely to incorporate by reference into the Company's Registration Statement on Form F-10 (File No. [<u>333-292294</u>](http://www.sec.gov/Archives/edgar/data/1833141/000106299325017416/formf10.htm)) (i) Exhibit 99.1 to this Form 6-K, which were previously filed with the Form 6-K dated [<u>February 10, 2026</u>](http://www.sec.gov/Archives/edgar/data/1833141/000183314126000006/cybininc-form6xk02x09x2026.htm), and (ii) Exhibits 99.2-99.4 to this Form 6-K, which were previously filed with the Form 6-K dated [<u>February 13, 2026</u>](http://www.sec.gov/Archives/edgar/data/1833141/000183314126000012/cybininc-form6xkq32026.htm) (collectively, the "Original Form 6-Ks"). Following the furnishing of the Original Form 6-Ks, the Company discovered that the Original Form 6-Ks inadvertently incorporated by reference Exhibits 99.1-99.4 to this Form 6-K into the Company's Registration Statement on Form F-10 (File No. 333-289139).

**<br>INCORPORATION BY REFERENCE**

Exhibits 99.1-99.4 to this Form 6-K are hereby incorporated by reference into the Company's Registration Statement on Form F-10 (File No. [<u>333-292294</u>](http://www.sec.gov/Archives/edgar/data/1833141/000106299325017416/formf10.htm)).

------

**SIGNATURE**

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

---

| | | | |
|:---|:---|:---|:---|
|  |  | **CYBIN INC.** | **CYBIN INC.** |
|  |  | (Registrant) | (Registrant) |
| Date: | March 5, 2026 | By: | */s/ Greg Cavers* |
|  |  | Name: | Greg Cavers |
|  |  | Title: | Chief Financial Officer |

---

------

<u>**EXHIBIT INDEX**</u>

---

| | |
|:---|:---|
| [99.1](http://www.sec.gov/Archives/edgar/data/1833141/000183314126000006/helusceopressreleasedraft-.htm) | [<u>News Release dated February 10, 2026 (incorporated by reference to Exhibit 99.1 to the Company's Form 6-K filed with the Securities and Exchange Commission on February 10, 2026)</u>](http://www.sec.gov/Archives/edgar/data/1833141/000183314126000006/helusceopressreleasedraft-.htm) |
| [99.2](http://www.sec.gov/Archives/edgar/data/1833141/000183314126000012/cybin-financialstatementsx.htm) | [<u>Interim Consolidated Financial Statements for the three and nine months ended December 31, 2025 (incorporated by reference to Exhibit 99.1 to the Company's Form 6-K filed with the Securities and Exchange Commission on February 13, 2026)</u>](http://www.sec.gov/Archives/edgar/data/1833141/000183314126000012/cybin-financialstatementsx.htm) |
| [99.3](http://www.sec.gov/Archives/edgar/data/1833141/000183314126000012/cybin-mdaxq3x26.htm) | [<u>Management's Discussion and Analysis for the three and nine months ended December 31, 2025 (incorporated by reference to Exhibit 99.2 to the Company's Form 6-K filed with the Securities and Exchange Commission on February 13, 2026)</u>](http://www.sec.gov/Archives/edgar/data/1833141/000183314126000012/cybin-mdaxq3x26.htm) |
| [99.4](http://www.sec.gov/Archives/edgar/data/1833141/000183314126000012/q3earningspr2026.htm) | [<u>News Release dated February 13, 2026 (incorporated by reference to Exhibit 99.5 to the Company's Form 6-K filed with the Securities and Exchange Commission on February 13, 2026)</u>](http://www.sec.gov/Archives/edgar/data/1833141/000183314126000012/q3earningspr2026.htm) |

---

------